BTG Share PerformanceMore
|52 week high||739.5 12/07/16|
|52 week low||528.4 31/01/17|
|52 week change||39.0 (5.99%)|
|4 week volume||17,129,850 01/06/17|
Latest News« previous» nextMore
23/06/2017 - 15:11 RNS
RNS Number: 0582J BTG PLC 23 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualif...
21/06/2017 - 10:01 RNS
RNS Number: 7210I BTG PLC 21 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualify...
16/06/2017 - 16:35 RNS
RNS Number: 3830I BTG PLC 16 June 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price...
16/06/2017 - 08:17 StockMarketWire
BTG has highlighted trial results which showed that patients with post-thrombotic syndrome can be treated safely and eff...
16/06/2017 - 07:00 RNS
RNS Number: 9604H BTG PLC 16 June 2017 ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome Bothell, WA, 16 June 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the ACCESS PTS trial , presented at the Society for Vascular Medicine 28 th Annual Scientific Sessions in Ne...
13/06/2017 - 14:26 StockMarketWire
BTG has confirmed that it intends to hold its Annual General Meeting on 13 July. At 2:26pm: (LON:BTG) BTG PLC share p...
13/06/2017 - 14:11 RNS
RNS Number: 9705H BTG PLC 13 June 2017 BTG plc 13 June 2017 ANNUAL REPORT AND ACCOUNTS 2017 In accordance with the Listing Rule 9.6.1, copies of the following documents have been submitted to the UK Listing Authority and will shortly be available for inspection via the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM A copy...
12/06/2017 - 15:45 StockMarketWire
Rolf Soderstrom, Financial Director, has transferred in 42,624 shares in the company on the 9th June 2017 at a price of 0.00...
|Dividend yield||0 %|
Equity Research (BTG)
Growth across all three divisions of BTG’s Interventional Medicine (IM) franchise (oncology, vascular and pulmonology), coupled with currency tailwinds, helped push FY16 revenue towards the upper end...
BTG’s interim results have driven upgrades to our financial forecasts with a small boost to revenues from one-off Zytiga backdated royalties. Our operating expenses are broadly unchanged, but...
BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of £410-440m (at $1.61/£). This is based on slower-than-expected Varithena sales, despite a...
- 1 of 3
Latest discussion posts More
“Perhaps our increasing SP & rating will tempt The Dame to buy Vectura to put me out of my misery & increase my decent holding here substantially !”▼
“Coooore blimey governore apparently some spivs are shorting or snorting the stock hey ho love and kisses from a long term btg holder”▼
“This is more good news for BTG and our EKOS therapy . BE HAPPY DAVE ACCESS PTS Study Demonstrates Efficacy of EKOS? Therapy for Post-Thrombotic Syndrome Bothell, ...”▼
Codes & Symbols
|Symbols||BTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG|